| Shareholder Update: Mill City Evaluating the Pharmaceutical Compounding Space | |
| | |
|
CALGARY, ALBERTA--(Marketwired - May 1, 2015) - MILL CITY GOLD CORP. ("Mill City" and/or the "Company") (TSX VENTURE:MC)(FRANKFURT:NJ6) is pleased to announce it is currently reviewing and evaluating a number of opportunities in the pharmaceutical compounding space. Pharmaceutical compounding ("Compounding") is a branch of pharmacy that continues to play a crucial role of drug development. Compounding is the creation of a particular pharmaceutical product to fit the unique need of a patient. To do this, compounding pharmacists combine or process appropriate ingredients using various tools. ON BEHALF OF THE BOARD OF DIRECTORS James R. Brown, Chairman, President & CEO The TSX Venture Exchange has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.
|
|
|
Mill City Gold Corp
|
|
EXPLORATEUR |
CODE : MC.V |
ISIN : CA5998052073 |
|
| |
ProfilIndicateurs de MarchéVALEUR : Projets & res.Communiqués de PresseRapport annuelRISQUE : Profile actifsContactez la cie |
Mill City Gold est une société d’exploration minière d'or basée au Canada. Mill City Gold détient divers projets d'exploration au Canada. Ses principaux projets en exploration sont SOUTHERN STAR EAGLE, CROXALL, NORTHERN STAR EAGLE et GP2 au Canada. Mill City Gold est cotée au Canada et aux Etats-Unis D'Amerique. Sa capitalisation boursière aujourd'hui est 17,1 millions CA$ (12,7 millions US$, 11,3 millions €). La valeur de son action a atteint son plus haut niveau récent le 05 novembre 2010 à 1,87 CA$, et son plus bas niveau récent le 25 octobre 2013 à 0,01 CA$. Mill City Gold possède 89 939 000 actions en circulation. |